The
Renaissance
Series
TRANSFORMING VALUE
TRANSFORMING TRUST
Building patient trust and belief in the value of medicines
Join us in Paris on 10th June for our latest Thought Leadership Forum
PARIS 2022
More Details
What is Renaissance
Goal & Purpose
Building patient trust in pharma is now more important than ever and a change in how pharma recognises and communicates patient value is imperative.
“What steps must we as an industry take to build patient trust and belief in the value of medicines?”
PARIS FORUM
- A unique opportunity to spend a day in closed meeting discussion of the most important challenge for pharma today
- Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing this challenge
- Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies
Expert Faculty
Stuart Cooper
CEO, Adelphi Group
David Gillen
Chief Medical officer, Norgine
John-Kenneth Sake
Medical Lead Neurology & Immunology Merk KGaA
Neil Bertelsen
Patient Advocate & Patient Engagement Specialist
John Irwin
Consultant in Market Access: Expert Orphan Medicines & ATMPs
Bernard Revaz
Technologist CEO, Ayaru
What is the Renaissance Series?
Expert exchange on disruptive drivers in healthcare
Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.
One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:
- Striving for Transformational Value 2018-2020
- Patientcentricity: Defining our role 2016-2017
- Real World Evidence: the new standard of proof? 2014-2015
- Personalised Medicine: Moving from promise to practice 2012-2013
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.
Goal & Purpose to PARIS 2022
More Details
What is the Renaissance Series?
Goal & Purpose
Building patient trust in pharma is now more important than ever and a change in how pharma recognises and communicates patient value is imperative.
“What steps must we as an industry take to achieve the desired transformation in healthcare?”
Why Attend?
- A unique opportunity to spend a day in closed meeting discussion of the most important challenge for pharma today
- Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing this challenge
- Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies
In this invitation only meeting, designed for Senior Pharmaceutical Executives across disciplines, Adelphi invites you to engage in thought-leading debate on the role of the pharmaceutical industry in embracing the change required in the quest for Transformational Value.
Expert Faculty
Stuart Cooper
CEO Adelphi, Meeting Chair
David Gillen
Chief Medical Officer, Norgine
John-Kenneth Sake
Medical Lead Neurology & Immunology Merck KgA
Patrick Papazian
Patient Advocacy & Innovation Director, Galapogos and practising physician
Neil Bertelsen
Consultant in Market Access; Expert Orphan Medicines & ATMPs
Bernard Ravaz
Technologist CEO, Ayaru
What is the Renaissance Series?
Expert exchange on disruptive drivers in healthcare
Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.
One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:
- Striving for Transformational Value 2018-2020
- Patientcentricity: Defining our role 2016-2017
- Real World Evidence: the new standard of proof? 2014-2015
- Personalised Medicine: Moving from promise to practice 2012-2013
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.